In This Article:
If you want to know who really controls Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049), then you'll have to look at the makeup of its share registry. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.'
Jilin Province Huinan Changlong Bio-pharmacy is not a large company by global standards. It has a market capitalization of HK$706m, which means it wouldn't have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have not yet purchased shares. Let's delve deeper into each type of owner, to discover more about 8049.
See our latest analysis for Jilin Province Huinan Changlong Bio-pharmacy
What Does The Lack Of Institutional Ownership Tell Us About Jilin Province Huinan Changlong Bio-pharmacy?
Small companies that are not very actively traded often lack institutional investors, but it's less common to see large companies without them.
There could be various reasons why no institutions own shares in a company. Typically, small, newly listed companies don't attract much attention from fund managers, because it would not be possible for large fund managers to build a meaningful position in the company. It is also possible that fund managers don't own the stock because they aren't convinced it will perform well. Jilin Province Huinan Changlong Bio-pharmacy might not have the sort of past performance institutions are looking for, or perhaps they simply have not studied the business closely.
Jilin Province Huinan Changlong Bio-pharmacy is not owned by hedge funds. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of Jilin Province Huinan Changlong Bio-pharmacy
The definition of company insiders can be subjective, and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
Our information suggests that insiders maintain a significant holding in Jilin Province Huinan Changlong Bio-pharmacy Company Limited. Insiders have a HK$238m stake in this HK$706m business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.